{"id":6936,"date":"2015-01-02T11:25:33","date_gmt":"2015-01-02T10:25:33","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=6936"},"modified":"2015-01-02T11:30:22","modified_gmt":"2015-01-02T10:30:22","slug":"novartis-chiude-vendita-di-animal-health-eli-lilly-con-plusvalenza-di-46-mld","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/novartis-chiude-vendita-di-animal-health-eli-lilly-con-plusvalenza-di-46-mld\/","title":{"rendered":"Novartis chiude vendita di Animal Health a Eli Lilly con plusvalenza di 4,6 mld $"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" alt=\"\" src=\"data:image\/jpeg;base64,\/9j\/4AAQSkZJRgABAQAAAQABAAD\/2wCEAAkGBxITEhQUEhQVFhUXFxUbFxgYFxQYGBwXGBcXFxgXGBQYHSggGBwlHhUWITEhJSkrLi4uFx8zODMsNygtLisBCgoKDg0OGhAQGywkICQsLC0sLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLCwsLP\/AABEIAMAAvQMBEQACEQEDEQH\/xAAcAAABBQEBAQAAAAAAAAAAAAAAAQMEBQYCBwj\/xABBEAABAwIEAwUEBwcCBwEAAAABAAIDBBEFEiExBkFRE2FxgZEiMqGxBxQjQlLB0RUzU3KC8PFD4RckRHOSssIW\/8QAGgEBAAMBAQEAAAAAAAAAAAAAAAECAwQFBv\/EADARAAICAQMEAAQFBAMBAAAAAAABAhEDEiExBBNBUSIyYXEFFDOB8CORocGx0eFC\/9oADAMBAAIRAxEAPwD2bEqvso3SZS4N1cBvl5kDnZZ5J6I6jTDj7s1C6sr8bq+0oZZIHn905zXNNiLC\/kVr084zcWt0zDrcc8UZxezRU\/RjVSy0z3yvc8mQgFxJ0DW6C\/fddPVxjGdR9HF+GznPG5Td7mxXKegCAEAIAQAgBACAEAIAQAgBACAEAIAQAgBACAEBS8W14ipZOrwWNHe4W+S5uryrHif1O78OwvL1EV63f7FVwjSk4fI07P7XL4EW+YJ81n+FpxxL7l\/x2Snmkl6ph9GLcuHtJ5ukJ9bfkvV62SU2\/SPA\/DY\/0V9WzVxStcAWm4K5IZIzipRdo75RcXTHFcgRzrC52QHMcgcAWkEHUEbEeKPYhNNWhmWviacrpGNd0Lmg+hKlRb4RV5Ip02SLqC5CqMZpmOyvmia7oXtB8xfRWUJPhGcs2OLptEuOUOF2kEciCCPUKvGxdNNWMNxKEmwljJva2dt79LXU6XzRXuQurQ7PUMYLvcGjq4gD1KJN8FnJJWxYZ2vF2ODh1BBHqFDVchNPgI5muLgCCWmxtyNgbHyIU0wmnwLJIGglxAA3J2UE2Rv2rT7dtFc7e2z9VbRL0Z92HtEoOVTTkinFYASDNGCDYgvYCCNwRdW0S9Gfdh7QftWD+NF\/5s\/VNEvQ7sPa\/uPz1DGC73NaOriAPUqEm+C7kkrbCCpY8XY5rgObSCPgjTXIUlLhnFZXRRC8r2sHIuIHpdFFvgrPJGHzOjqmqmSNDo3Ne082kEeoRprkmMlJXF2YDjaV01ZHADYDK0eMh1PovD65vJmWP+bn1H4VFYellm8u\/wDBvqenaxjWNFmgAAdw0XswjpSS8Hzc5Obcn5KngunyUkbehf8A+7lvndzs5OkjWJIajnMNU5g9x5GnQkbjzXy8Mz6Xr3jXyya2+r\/9PdljWbplLyjRL6M8sYrf3b\/5XfIqY8opP5X9jznhfGJaBsDKj2qWdrXRyfw3OGrD3f5Xdmxxy3p5R5XTZpYFFZPllw\/Vmpx8B1Th7hY\/avIO+hicdD5Lnx3omvoduenkxv6\/6GOPsTfHHFFG4tdPII8w3DSQCQeR1U9NDU234K9blcIqK8ui8pMJhjjETY25LWIyjXqT1JWLnJu7OiGDHGOlJUY+haaHFBTx6QVDczWcmus7YctWn1XXL+ph1PlHBBvB1XbXyy\/n+h3jSH6tVU1c0aBwZL3tNxc+RI8gq4Hrg8Zbq49rLHMvsy34rd2zYaVv\/UOGY9IWWe8+Ys3+pZYdrk\/Bv1L16ca8\/wDHJb1czIIXPNgyNhNu5o2+CzSc5V7N5NY4N+EY3hSeWCtdFOdatgmHc+xLmeIGn9IXVmUZY7j42PP6aU8ebTP\/AOtze2XGeoefcK0kD4q8TNYW9tJfMG6C29+S7crknHT6PK6aONxya65Ze\/R7BIyijEmbdxYHbiMn2b326271j1DTybHT0MZLCtX8Q7j+EwMpKgtiZfs5TmLWl1yCScxF73UY5yc0rJz4oRxSpLhkLg7CoJKCnzxMJLd8rc1w82Oa176K2eco5GkynSYoSwRbSLbito+pVH\/af8lnh\/URv1K\/oy+xG4EH\/IU1vwf\/AEVbqP1GU6L9GJS49iApMSbNUMLoZIgxj7XyOBu6w7+dtbLXHHXiqL3Rz5sna6hTmvhaq\/RrMMhiDS6G2SQ57ttlJda5Fuu65puTdS8HdijBK4cPcy3GOEytmZVwtLsuUuaN7sNwe8EaLyOtwTU1mhv7PovwzqscsT6bI6vh\/c1WF4jHOwPjcCDuOYPMEcivRxZY5Y6onj5+nngnomh1obEzezRc6+N1bJkjBa5ukjHHjfyxRn6WF09R2tiGBwIJ55drL5nBhn1vV9+qgmt\/dcHr5Jx6fB2r3\/7NQvqDyCJisobDIXEAZH6n+Uq0PmRnlaUG36KLhymhqcNhieA9piaHDmCB8CFrlcoZW0c3Txhl6eMXvsUeHUFRTVlNTSEvga+R8Mlth2bgWHw3st5TjPHKa58\/3OaGPJjzQxveKez\/AG4Lvj3BnzwtfCLywuD2jrbcDv0Cw6fIoyqXDOnrcMskE48rckYTxXTSx3fI2KQD245CGOaRvo5RPBNPZWXxdXjlH4nT82V9FTGrxAVYBEMLMkRItncc13Nv90ZjrzV5S7ePR5ZjCHez95fKlS+pfcQ4YKmnlhP3mmx6OGrT6rHFPRNM6s+LuY3EoeAYpZGCece0xggZ\/LGTnd4l2n9K26hpPTH7nL0KlJa5+Nl+xJ4pqGTSQUQeB2j7y2NiI4\/at3Fzg0KMKcU8nov1LU3HFfPP2KrjXCPq8cdVE6RzoJGn23uf7JIBAudNbK+DJrbg1yYdZhWOKyRu0zYYdiUc0TZWOBaQCdRppqD0suaUHGVM9DHljOOpMwHDGEU1W2tY\/LnMz8j9MwF7hze667cs5Y3F+KPL6fDjzKafN7M0HDOOua40lYcs8ejXHQSN5OBPOywy4r+OHH\/B1dP1DT7WXaS\/yWnFcobR1BJAvG8eZabALPDvNfc26ppYZX6If0fzNdQQAEEhpBHMHM7cK\/Up912Z9DJPBGiXxfKG0dRc2vG4DxI2Heq4f1EadVJLDK\/RF4CmaaCnAIJDLEX1BudCOSt1CrI7KdFJPBE6xDFKSUz09S6MBhF2vIF2lrXB4v48uiiMJrTKInlxT1QyNbEb6O6ZzKZwN+zMrzFmvcx39k279\/NW6lqU\/r5+5XoIOOP6Xt9jVFc52kU0EebPkAd+IaE+JG6p243dbmnenp03t6HZKdrjdwBttfVVnhxzdyV\/cqpySpMcC1KioDlzQdxdCKBrANgEJFIQCoBqSnYTctaT1IBPqlshxT8DoQkEByAgOezHQeiEUjoi6Dk5EY10Gu+gQUkDYxfYegQUhXsB3APihNAWg7gFADWAbABCKSFc0HcXQmhGsA2ACEUcyQtcQXNaSNiQDbwul0HFPkcuhIqAEAIAQAgBACAEAIAQAgKOqxvLWRwezkcMpN9RIQXsFumVp9QtVjuDkcss9ZlDx\/vwMHHnNlljkAaC5zYZORc1oOR\/R3MdQp7VpNfuR32nJS25pjsGIymWlYSLSQvc\/T7zQ3bXT3tlDgtMn6ZaOSWqCflWQ3cSuEFQcn2zHOyN\/Ew3LH+GUOJ\/lKv2fiS8Gb6p6JPyuPt7JeM492LYXCxDsrn3\/hktaSO+7wfAFUhj1WXy59Ci\/wCV\/GShWP8ArYiuMhhL9tb5g3fpqq0tF+bL633dPir\/AMiY\/Xvi7DLs+ZrHDLmOUhxNh10U44qV\/YZ8jhpry6IseKyOkqgNGxxscwFtiCWuJvfcaBWcKjH6lFllKU0vC9HNHi7\/AKqZnuu4tYQHM7MZ3tFgCfeF3DVTLH8elFYZ32tbfheK3Zycbe6lhmYQHOkjY8WuAS\/s5APO9lHbSm4viie+3ijNc2k\/7j+M1E0ckIbI0NllDLFgOUZHOve+pu1RjUXF7cFs0pxlFJ8uuA\/aEjKjsnkvAha72YzfNmyk2F7DuRxTha9juSjk0vfbwvqSOHK180DZHkZi540FtGvc0aeAUZY6ZUi3Tzc4amWqzNwQAgBACAEAIAQAgBAIQgK2bBInMcx2b2pBJmv7QeCHAh3dlHktFkaZi8EWmvrZ3Jg8TmSxvBeyUkvDupAGnTYFR3Haa8EvDFpxe6Yv7KZnjfd142OY3XTK4AG\/U6BNbpr2OyrT9KhtuBQ6EtJcIjFmJ1yHcX\/NT3Zf5sjsQ9eK\/YWLBYg1zTmcHRtjOY39hoIsPUo8juwsEap77UcDAmAscJJQ5sYjBzC5YDexuNTpup7r3VEdhWmm9lRKrcPbL2eYu+zeHtsbe0AQL9dyqRlpv6l541Kr8Oxt2EsL5X3deVoa7XSwBAsOR1KnW6S9DtK2\/Y3T4MxojGeRzYy3IHEEDK0tA21sCpeRu9uSkenjFJW9huXAYnZxd4D5GykB1rPFjcdNQDZFld\/tQfTxd7vmx+XCmu7LM97jG\/O0ki+axGum1nHRQp1deSzwp1bezsdGHt7YzXOYsyb6Zb3263Uanp0k9ta9fmqDDsPZCzIy9ruOpubuJcdfElJScnbEMahGkS1U0BACAEAIAQAgBACAEAIAQAgBACAEAIAQAgBAUWKV\/ZVEdz7LhY\/JcmWenKjbHDVFl4F1mIqAEAIAQAgBACAEAIAQAgBACAEAIAQAgBACAEAIBCUBh8VrBNXMY3UNIH5rzcsteVUd0FoxOzcBeijhFUgEAIAQAgBACAEAIAQAgBACAEAIAQAgBAMx1LC4tB1HJUU03ROl1Y8rkAgM7xljHYQkD3naDzXJ1OXSqR0dPj1O2VP0fUQcXzOHtfqsulgm3I06mVfCbcL0DjFQAgBACAEAIAQAgBACAEAhQEOqxWKP3ni\/dqspZYouoNkB\/EsezGud8FT8wvCLdmQ7BjzL2kBYTtfUK0cvtEPG0WkcgcLggjuWqafBm1R2pA3O+zXHoCVWTpMlcnnwxVzZM4voV5cW1LUerLEnCjRwcVxkC418Ry3XV+bS5RxPpZLgl\/8A6GHqfh+qv+agV\/LzMhxK8VUos6zRrbfQC115+bIsk9jsw43jjuTcKqSzKxh0+fkr45STpFcsU42zcN2Xqo84VSAQAgBACAEAIAQAgBAcyPDQSTYDcqG6HJ5\/xbxlZ3ZQnxK4M3UanpiduLBW8jKtrHHV2vnouakdVMk0WI2cLG4urR2IlH2WOL44Xi1hYabXKvLJexlGFO2M4JxM+F4ubtPI6D0UY8koMtkwqfB6VhOJsnYHMPiOi9HHkU1sedODi6Y7iP7p\/wDKf91OT5WIco8epoRJNNndbK+1tQduS8uj2G6ii0DGtbprbZYSRWGRDQkObb+7Kto1pj8UeYXBsTZXxrczk2WHChe6oDHstl1vquvDG5o5s+0D0ML0jzxUAIAQAgBACAEAIAQAgPNeP+LQHmniJOUHMQdCei4c89T0o68GPyzG4FTCVxe82b4alc8vhVHUyZXPY11m2HTXVZ2yyaIvukFWi7JbOnSOOqq5E6Raqie5mdoBt6jvHVE2VbO+CuIXwygZtL6\/4WsZOL1GWTHqR7XUvBiceRYT5WXoydwbPOXJ5mXxvcQC24PgvIW7PV4Q+KVtnAPaTbkQT6LVwsprorzSvEpYDoOfdv8AqFhW9G3c+EnuhcACOQHktdNGalaNNwdTG7pHEl1ra8l19LHdyOTqH4NSu05QQAgBACAEAIAQAgBAef8A0i8a\/VrwRe+RYnpfouXLmd6UdGLFe7PIu2c9j3k+292W56afqVy+TsWyL2Kjl7E9kctm2HpuqraVsNmYwuCcze3mJG5uTf12K2m4NbGMFJGp7Nxtfdcy2Z0EXGJnRxPI3AVoQt7kTltsROF+I5Dma\/VoGhA+BW04JGUW2RIqi8kluWqyaND1DgfjVktK6GQ\/aMYQ3vbt8F1RyVBpnJLE9WxUMqA2TNk2N+ViFxJ0ztSuJGFA5sjZWPblzNI1N7XuRl662Oq6Y5I0YPHKy9xCUsY57PfcLN8ToNfNZxUVOy0k9NEDBYZw53avcL3ABNzuCLi\/IX1V8so+CmOEo8nqGC0nZxtF7kgEnyXXggoxOTJLVIsFsUBACAEAIAQAgBACARAfP30ph31x9z3\/ABXmT+c9DF8hnIiexeehB\/x6KHyaeDbcNS5oh39FWRVMl0lE0uLiQAfdHd1UIs5MlF8Y2aL7BW2K22RcboA6MkjTmjRNlfFh0ccLrAai6hybaGmjEUX+ofH5q8iRqkqDG8PG4O3jvpurVsVXJvsMqcxB68jfmstkWdmhiijc3TTe\/j4KUrIujiCje7ciw6c++3RTLHRZ5LJXZMadN+vesJ8ELc2vD1XnjA5t+S9LpZ6oUcOaGmRarpMQQAgBACAEAIAQAgBAeQfS3hH24kGudo0+B+S8\/PGp2jt6eVxo877Mhr2jpf0OyouTdrYt+C8xDmNJLWu1PIA7\/JJoouS4x+udE2+UWG1tws47s0k6RkjxK7Ne+l9tV1PDtZyvqN6NRhmPdsPvaaWG2u91zyuJvBqRDxrEjHG5lrnUNPjtdVhuy0jPRxZIrc3aq0uQuBihp8zwLXJNlewbqOgcxoy2NhqPyWLe5ZEuincBcCx7lXUKRJfiEr7XFxy6I8jZdY0iwpgcoLt1XcozQcMVFpLDYrp6WVSow6hXGzXL0zgFQAgBACAEAIAQAgItbXxxC73Ad3NZzyRjyWjFy4MDxTicdWQ1g20J3O\/XluuHNlU3sdmGDhyef1FAQ+RttS12XxP56FZRe+50ujrgeo7F8jHbOA25EXt47\/Fay3Rhwyx4phLmEtF7qkVpdlpbo85OFyDQDQ8gdfRdazbHM8G5uuFaAhguCNPkuTJuzpgqOeMy3s8rRdxI8rd\/VRBUS3ZTz017dwHySXJK4LPBKNoeHKWwa2O3MLPkDzbX526CyhxIseiDSRv5qFFIWyXO0aWKs1ZCVFhw+LTBaYF\/UK5vkNmF6p54qAEAIAQAgBAcucALnQJYMlxFxeyO7YyD3\/ouTJn8I3hhvdnndbjMk78oOYk\/3quKUnI7YwUUWlNAIxlG\/wB48yoSIZVYwHuNmbixB9f1V0EU9JSFrgSNvne60SM2y5kqG+6Wmx3118lNCyEMPp81xe47hfwUNCyXJWC2jnabC+\/iq6SyZmsRnc57U4JXNnbJnaEgEa6X7iorclst8DjLhmOvckkQmXgqADaxFuqrRazmCozPtff8kIou4AwCznkpRA8co2KEk3ApPtmlWxOpmeX5Dbr1TgFQAgBAI51t0BEdiUY5qnciW0ManxqFgJc9Q8sUT25GF4p4v7QZI7tb8SuTLm17I6MeKt2ef4hiIIN\/A6\/FYpWza6O+EWZnPf8Ah0HmktiUzY07b2PIHVVSIZXV8eV5e05mncHkVeiEztga5txv0WiKSIU8FwpBGiaAT\/fJAVuJTu2aqNlkiFHG7ms2zVIZrHfZ6d\/z\/wB1eHNFZGg4dqcrBYXVZS3CiWEjb6j7ylEMj00Rc8MNwOZCqyys2dNBGQ1g1PL0UqKbpFJSaI9fTuj94WuplDSyIzvYsuGGZpG22U4Y3MjM6iboL0zhFQAgItbXNjFzqeipKaiWjFsyWNcR5xYDL0vz9Fy5MrZvDFRm58YFrFt7953WDdmyjJFZLWZja2h5G+\/mq6WWKnE8ouSfK6mMLEpUjFVNe5zjlGmvouiOOjBzN3wewCFvUknzWOTZmy4NPiFT2bLaDTW\/MqtgzTsbaDZ39+autyrXklwVTSQWadVJXUTHWcrEWcspmjfvshKKvEobnQLNmiGDSnctNuqqWTKrGGhrLDUWH+FePIZbcNy+yPDks5clka+Sia2ja+wBzOA7yStEvhszct6KLDqaQuLnPA7u5YtmqZt+EqK8mYm+XX1W\/TQuRz52WXGcA7ESfhOvgV0ZoGGJ\/EVnA9QHSEDofkufp\/1DfqflNyvROIEAIDIcR4dOZC6NpLTvb5LlnB3ZtGaop\/2dN\/CJPL2XWHmd1lpZfWht\/B00liG28dPHdFimy3fSA\/R\/OTfM31Vvy8iH1FkOu+iyeUEGdrQe4k+oWkcUkZvKU\/8AweqI\/dex4HLYqXBkax7C8DfSns3sIGa4vqL6c\/ELmnCtzohO1RPr6cvBvb5\/H8gs2jVMw2NYbkuWjS+tjp02UxIZWxVD2WA1sdFsZM01Lipy6gA9fyQgYrMZ1tt33+SVZIy3HWNtckqKIciSzH4n6Bxsqtl1uLiJD4jbnqqrkukN8NnQdyrlZeCNLWVbsjYuVydOp1TVSKJbnVJGQLHXwWWqzR7HonDkIZEDzIXpYY1E4MsrY3xaQaZ\/gpyfKRi5MbwNVBkw6HRcOF6clnZnjcD1AL1TzhUAIBEAIAQCoAQAgKvH6UOiceYGnVY5l8Nl8b3PPK1lx7egHut\/MlcLO0y2JsvfTRIhlDSxi7vEhbGVnFTPYgX23t3JQsabSumdpfINz+Q71DdE0yxpMOYPuAjv\/RUciyiWn7LYBcNFvAKLLIaqm9mxw+HoqrktdCYRE5oFuvzVcm5eBbmcB1idvmqt7EqJeYM7MQpgrZTI6NNHUuXoLZHEQsddK+EtaLk25qs7aovjpMzmC4RVD\/Tde\/dYa73XM8MrOiWWNUerULXBjQ7ewuvQxpqO558qvYkK5AIAQAgBACAEAICo4irxGzLzcsM0tqNMa3PPMQGadrNSC0m\/IGxP5LjcWdakRXQ2eWmxGUkaeShKiW7KJ3Cz5CXRvsCTpb4LpgrMJbEjDOEyHOM5DrEZWgaefVRN0TAm4jSFmVuUNubNA5nuC55WzoTRzFSFrsrtCeRt8FWiGLVw5b8r\/wCQVKTYTRXVGHyy3ytuL+tlr2yjmrLKkoJgy3ZuuBsNVSWJsssqFo6F5IzNIdzu06nxWcoNbGiyxNNguHvc4FrTz5clfDCRlkyxZrIcK6rv0nG5D4w0KdJGol08IaLBXRV7j6kAgBACAEAIAQAgBAVeM4M2exLrEAgaXWU8ep2WjKjP1XCMhlEjXA2Frbclk8UjTuDMPBct7ue3wuSR8FHYk2T3jQYVw\/HEyx9o8zay2jCjOU2ytxzh+S+aHXqNj5dVSeKyYzooJcFnMznmM+y2zLtO56eCw7TNVkQ4eG6h5YXNOhv05EC6ntMnuou8N4Rbo6bU\/h5LWGH2Zyy+i+iwqJuzQttJm5Nj7aRg+6PRTpIs7EDeg9E0oWzsNClKiBVIBACAEAIAQH\/\/2Q==\" width=\"189\" height=\"192\" \/>Novartis, con effetto dal 1\u00b0 gennaio, ha finalizzato la cessione della divisione Animal Health Division a Eli Lilly per 5,4 miliardi di dollari. Come risultato della transazione, che rientra nel piano di rifocalizzazione del business del colosso elvetico in tre comparti principali (innovazione farmaceutica, eyecare e generici), Novartis metter\u00e0 a bilancio una plusvalenza prima delle tasse di 4,6 miliardi di dollari nel primo trimestre del 2015.<\/p>\n<p><a href=\"http:\/\/finanza.lastampa.it\/Notizie\/0,674396\/Novartis_chiude_vendita_di_Animal_Health_a_Eli.aspx\" target=\"_blank\" rel=\"noopener\">02\/01\/2015 10.10 \u00a0 Borse Internazionali LA STAMPA ECONOMIA<\/a><\/p>\n<div>FTA Online News<\/div>\n<div>\n<p>(RR)<\/p>\n<\/div>\n<p>Related news:\u00a0<a href=\"http:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/articolo.php?articolo_id=25119\" target=\"_blank\" rel=\"noopener\">Fusione Walgreens-Boots: nasce il colosso dei<em>drugstore<\/em>\u00a0per farmaci, bellezza e\u00a0<em>wellness<\/em><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright\" alt=\"\" src=\"https:\/\/encrypted-tbn3.gstatic.com\/images?q=tbn:ANd9GcQqkj7Zermx_lv1yNCKXkup1QTeQaxVdq7j0-_gkVixfy5WdBcV-w\" width=\"187\" height=\"270\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Novartis, con effetto dal 1\u00b0 gennaio, ha finalizzato la cessione della divisione Animal Health Division a Eli Lilly per 5,4 miliardi di dollari. Come risultato della transazione, che rientra nel piano di rifocalizzazione del business del colosso elvetico in tre comparti principali (innovazione farmaceutica, eyecare e generici), Novartis metter\u00e0 a bilancio una plusvalenza prima delle &hellip;<\/p>","protected":false},"author":4,"featured_media":2948,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[53],"class_list":["post-6936","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-fusioniacquisizioni"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/6936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=6936"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/6936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/2948"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=6936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=6936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=6936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}